Identification of TIMP2 as a Prognostic Biomarker and Its Correlation with Tumor Immune Microenvironment: A Comprehensive Pan-Cancer Analysis

Figure 4

Correlation of the TIMP2 expression with immune infiltration levels of B cells, CD8 + T cells, CD4 + T cells, macrophages, neutrophils, and dendritic cells in BRCA, COAD, HNSC, KIRC, LIHC, LUAD, LUSC, PAAD, STAD, and THCA.